Guang Peng Liang
Corporate Officer/Principal bei Edding Group Co., Ltd.
Profil
Guang Peng Liang is currently working as the VP-Supply Chain & Project Management at Edding Group Co., Ltd.
He previously worked as the Director-International Trade Department at Shanghai United Cell Biotechnology Co. Ltd.
from 2002 to 2011 and as the Vice President-Operations at Taizhou EOC Pharma Co., Ltd.
from 2016 to 2018.
Mr. Liang graduated from the University of Aberdeen in 2000 with a graduate degree and from Wannan Medical College in 1998 with an undergraduate degree.
Aktive Positionen von Guang Peng Liang
Unternehmen | Position | Beginn |
---|---|---|
Edding Group Co., Ltd.
Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01.06.2019 |
Ehemalige bekannte Positionen von Guang Peng Liang
Unternehmen | Position | Ende |
---|---|---|
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | Corporate Officer/Principal | 01.08.2018 |
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Guang Peng Liang
University of Aberdeen | Graduate Degree |
Wannan Medical College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of United Laboratories, Inc., Shanghai United Cell Biotechnology Co. Ltd. is an industrialized base that integrates the research and development, manufacturing, and sales of genetic reorganization biological products and vaccines. The company is based in Shanghai, China. The Chinese company has always adhered to the principle of developing high-quality drugs and vaccine products through innovation to better serve society and benefit humanity. The company's products include injection reorganization typa peptide reorganization B sub-sub-unit/bacterial cholera vaccine, injection of employment growth hormone in employment hormone. | Health Technology |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | Health Technology |
Edding Group Co., Ltd.
Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | Commercial Services |